Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Astrazeneca (AZN) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Astrazeneca (AZN) lobbying for?
Summary:
Astrazeneca hired 10 lobbying firms to lobby on various issues related to taxation, medical research, labor issues, pharmacy, health, environment, foreign relations, trade, budget, and appropriations. They lobbied on specific bills related to patent law reform, drug coverage and reimbursement, 340B drug discount program, price transparency, clinical trial diversity, user fees, and access to rare disease therapies, amongst others. They lobbied government agencies such as OSTP, White House Office, FDA, HHS, Senate, and CMS.
Inference:
One could infer that Astrazeneca is lobbying on these issues to protect their intellectual property and patents, increase funding for medical research, expand access to affordable healthcare, and promote sustainability initiatives. They may also be lobbying to ensure fair competition in the pharmaceutical industry, improve drug pricing reform, and support small businesses. Additionally, they may be advocating for policies that support clinical trial diversity and access to rare disease therapies to improve patient outcomes.
